KNTK Stock Analysis: Kinetik Holdings | NYSE
Oil & Gas Midstream | NYSE, USA | Market Cap: 9.226m USD | 12M Return: 64.3% | US02215L2097 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 68.7M
EPS Trend: -3.6%
Qual. Beats: 0
Rev. Trend: 99.0%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 9.4 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Kinetik Holdings Inc. (NYSE: KNTK) is a U.S. midstream energy company headquartered in Midland, Texas, focused on the Texas Delaware Basin - a sub-basin of the Permian Basin and one of the most prolific shale producing regions in North America. The company was founded in 2017 and trades as a mid-cap stock in the Energy sector (GICS sub-industry: Oil & Gas Storage & Transportation).
The company operates through two business segments: Midstream Logistics and Pipeline Transportation. Its services span the full midstream value chain, including gathering, compression, processing, stabilization, treating, and storage of hydrocarbons, as well as pipeline-based transportation and water gathering and disposal for natural gas, natural gas liquids (NGL), and crude oil producers. Kinetik also markets and sells condensates, natural gas residue, and NGLs.
As a midstream operator, Kinetik sits between upstream production and downstream refining/marketing, providing the infrastructure needed to move hydrocarbons from the wellhead to end markets. The Delaware Basin focus ties the business closely to Permian production volumes, meaning throughput and service demand are largely a function of producer activity in that region.
- Delaware Basin production growth lifts gathering and pipeline throughput
- NGL and natural gas price swings pressure product sales margins
- Capital allocation balances dividends with debt reduction efforts
| Net Income: 476.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -4.13 > 1.0 |
| NWC/Revenue: -23.52% < 20% (prev -11.45%; Δ -12.07% < -1%) |
| CFO/TA 0.09 > 3% & CFO 639.7m > Net Income 476.7m |
| Net Debt (4.02b) to EBITDA (1.23b): 3.27 < 3 |
| Current Ratio: 0.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (75.8m) vs 12m ago 22.89% < -2% |
| Gross Margin: 40.07% > 18% (prev 35.69%; Δ 4.38% > 0.5%) |
| Asset Turnover: 26.28% > 50% (prev 23.10%; Δ 3.17% > 0%) |
| Interest Coverage Ratio: 3.71 > 6 (EBIT TTM 827.6m / Interest Expense TTM 222.8m) |
| A: -0.06 (Total Current Assets 68.8m - Total Current Liabilities 512.4m) / Total Assets 7.20b |
| B: -0.23 (Retained Earnings -1.68b / Total Assets 7.20b) |
| C: 0.12 (EBIT TTM 827.6m / Avg Total Assets 7.18b) |
| D: -0.28 (Book Value of Equity -1.19b / Total Liabilities 4.29b) |
| Altman-Z'' = -0.68 = B |
| DSRI: 3.0 (Receivables 285.9m/62.9m, Revenue 1.89b/1.65b) |
| GMI: 0.89 (GM 35.69% / 40.07%) |
| AQI: 1.03 (AQ_t 0.44 / AQ_t-1 0.42) |
| SGI: 1.14 (Revenue 1.89b / 1.65b) |
| TATA: -0.02 (NI 476.7m - CFO 639.7m) / TA 7.20b) |
| Beneish M = -1.36 (Cap -4..+1) = D |
As of October 17, 2026, the stock is trading at USD 55.30 with a total of 897,354 shares traded. Over the past week, the price has changed by +3.44%, over one month by +2.71%, over three months by +12.65% and over the past year by +64.31%.
Current recommended Stop Loss: 53.10 (which is 4% or 1.4 ATR below the current price).
Kinetik Holdings has received a consensus analysts rating of 4.24. Therefore, it is recommended to buy KNTK.
- StrongBuy: 8
- Buy: 5
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 57.5 | 4% |
P/E Trailing = 19.0664
P/E Forward = 21.4133
P/S = 4.8926
P/B = 1.3379
P/EG = 8.6228
Revenue TTM = 1.89b USD
EBIT TTM = 827.6m USD
EBITDA TTM = 1.23b USD
Long Term Debt = 3.70b USD (from longTermDebt, last quarter)
Short Term Debt = 260.5m USD (from shortTermDebt, last quarter)
Debt = 4.03b USD (from shortLongTermDebtTotal, last quarter) + Leases 51.5m
Net Debt = 4.02b USD (calculated: Debt 4.03b - CCE 7.83m)
Enterprise Value = 13.2b USD (9.23b + Debt 4.03b - CCE 7.83m)
Interest Coverage Ratio = 3.71 (Ebit TTM 827.6m / Interest Expense TTM 222.8m)
EV/FCF = 68.23x (Enterprise Value 13.2b / FCF TTM 194.2m)
FCF Yield = 1.47% (FCF TTM 194.2m / Enterprise Value 13.2b)
FCF Margin = 10.30% (FCF TTM 194.2m / Revenue TTM 1.89b)
Net Margin = 25.28% (Net Income TTM 476.7m / Revenue TTM 1.89b)
Gross Margin = 40.07% ((Revenue TTM 1.89b - Cost of Revenue TTM 1.13b) / Revenue TTM)
Gross Margin QoQ = 59.14% (prev 29.13%)
Tobins Q-Ratio = 1.84 (Enterprise Value 13.2b / Total Assets 7.20b)
Interest Expense / Debt = 5.53% (Interest Expense 222.8m / Debt 4.03b)
Taxrate = 9.01% (54.5m / 604.7m)
NOPAT = 753.0m (EBIT 827.6m * (1 - 9.01%))
Current Ratio = 0.13 (Total Current Assets 68.8m / Total Current Liabilities 512.4m)
Debt / Equity = -3.40 (negative equity) (Debt 4.03b / totalStockholderEquity, last quarter -1.19b)
Debt / EBITDA = 3.27 (Net Debt 4.02b / EBITDA 1.23b)
Debt / FCF = 20.71 (Net Debt 4.02b / FCF TTM 194.2m)
Total Stockholder Equity = -1.30b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.64% (Net Income 476.7m / Total Assets 7.20b)
RoE = -36.70% (negative equity) (Net Income TTM 476.7m / Total Stockholder Equity -1.30b)
RoCE = 34.46% (EBIT 827.6m / Capital Employed (Equity -1.30b + L.T.Debt 3.70b))
RoIC = 10.85% (NOPAT 753.0m / Invested Capital 6.94b)
WACC = 7.42% (E(9.23b)/V(13.3b) * Re(8.46%) + D(4.03b)/V(13.3b) * Rd(5.53%) * (1-Tc(0.09)))
Discount Rate = 8.46% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 83.58 | Cagr: 12.30%
[DCF] Terminal Value 73.10% ; FCFF base≈311.8m ; Y1≈273.4m ; Y5≈220.9m
[DCF] Fair Price = N/A (negative equity: EV 3.55b - Net Debt 4.02b = -474.6m; debt exceeds intrinsic value)
EPS Correlation: -3.60 | EPS CAGR: -1.74% | SUE: 0.63 | # QB: 0
Revenue Correlation: 99.01 | Revenue CAGR: 17.36% | SUE: 4.0 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.36 | Chg30d=+0.00% | Revisions=+40% | Analysts=2
EPS current Year (2026-12-31): EPS=1.47 | Chg30d=+0.00% | Revisions=+17% | GrowthEPS=-52.4% | GrowthRev=+16.7%
EPS next Year (2027-12-31): EPS=2.18 | Chg30d=+0.00% | Revisions=+50% | GrowthEPS=+48.0% | GrowthRev=+14.2%
[Analyst] Revisions Ratio: +55% (up=7, down=1)